XML 47 R37.htm IDEA: XBRL DOCUMENT v3.19.2
Agreements - Roche (Details) - USD ($)
$ in Thousands
1 Months Ended 6 Months Ended
May 03, 2019
Jan. 31, 2019
May 31, 2000
Jun. 30, 2019
Jun. 30, 2018
Collaborative Agreements disclosures          
Non-cash royalty revenue related to sale of future royalties       $ 18,900 $ 14,432
Non-cash royalty revenue related to the sale of future royalties       18,900 14,432
Revenue recognized that was previously deferred       158 13,196
Roche          
Collaborative Agreements disclosures          
Period in arrears to receive royalty reports and payments related to sales of Kadcyla     3 months    
Percentage of royalty payments   100.00%      
Roche | Regulatory milestones          
Collaborative Agreements disclosures          
Revenue recognized that was previously deferred $ 5,000        
Roche | Kadcyla          
Collaborative Agreements disclosures          
Non-cash royalty revenue related to sale of future royalties       18,900 14,400
Non-cash royalty revenue related to the sale of future royalties       18,900 $ 14,400
Roche | Kadcyla | Regulatory milestones          
Collaborative Agreements disclosures          
Potential milestone payments       $ 5,000  
OMERS | Kadcyla          
Collaborative Agreements disclosures          
Non-cash royalty revenue related to sale of future royalties   $ 65,200      
Non-cash royalty revenue related to the sale of future royalties   $ 65,200      
Percentage of royalty payments   100.00%